Clinical Trial Update: SLV-324 Treatment of Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

SLV-324 is being studied in a Phase 1 trial for metastatic solid tumors, and recruitment is ongoing. The sponsor is Solve Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SLV-324

Snippet

Sponsor: Solve Therapeutics | Conditions: Metastatic Solid Tumors | Phase 1 | Status: RECRUITING